InsidersTradesSigma
Accustem Sciences Inc. Stock: price and management transactions · United States · SEC (Form 4)
Follow the Accustem Sciences Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Accustem Sciences Inc. has logged 12 reports. Market capitalisation: €5.1m. The latest transaction was reported on 13 June 2025 (Acquisition). Among the most active insiders: CERRONE GABRIELE M. All data is free.
12
Insider Decl.
0
Thresholds
€197,799
12 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 June 2025
Declarations12 total
28,205 shares@ US$0.39Common StockSEC:0001641172-25-015003:0
Ideal exit: 8 Mar 2026 (T+270)
35,000 shares@ US$0.66511.3% of flowCommon StockSEC:0001641172-25-003618:0
Ideal exit: 3 Jan 2026 (T+270)
35,000 shares@ US$0.6511.1% of flowCommon StockSEC:0001641172-25-003222:2
Ideal exit: 2 Jan 2026 (T+270)
100,000 shares@ US$0.44721.7% of flowCommon StockSEC:0001641172-25-003222:0
Ideal exit: 13 Dec 2025 (T+270)
17,802 shares@ US$0.6095.3% of flowCommon StockSEC:0001641172-25-003222:1
Ideal exit: 2 Jan 2026 (T+270)
100,000 shares@ US$0.38119.5% of flowCommon StockSEC:0001493152-25-000211:0
Ideal exit: 27 Sept 2025 (T+270)
5,000 shares@ US$1.403.5% of flowCommon StockSEC:0001493152-23-000064:0
Ideal exit: 26 Sept 2023 (T+270)
3,729 shares@ US$1.422.7% of flowCommon StockSEC:0001493152-22-034396:0
Ideal exit: 29 Aug 2023 (T+270)
24,500 shares@ US$1.0513.2% of flowCommon StockSEC:0001493152-22-033239:0
Ideal exit: 15 Aug 2023 (T+270)
10,000 shares@ US$0.794.1% of flowCommon StockSEC:0001493152-22-020942:0
Ideal exit: 28 Apr 2023 (T+270)
20,000 shares@ US$0.500.18% mcap63.9% of flowCommon StockSEC:0001493152-22-016256:0
Ideal exit: 5 Mar 2023 (T+270)
4,181 shares@ US$1.350.10% mcap36.1% of flowCommon StockSEC:0001493152-22-011318:0
Ideal exit: 20 Jan 2023 (T+270)
12 of 12 declarations
About Accustem Sciences Inc.
Accustem Sciences Inc. is a company focused on developing diagnostic solutions for cancer. It aims to enhance methods for detecting and monitoring oncological diseases.